跳至主要内容
临床试验/NCT04787471
NCT04787471招募中2 期

Randomized Comparison of Standard vs. Accelerated Corneal Crosslinking for Treatment of Corneal Neovascularization With or Without Concomitant Inflammation and/or Infection

Price Vision Group2 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2021年5月3日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
62
试验地点
2
主要终点
corneal neovascularization as a proportion of the total corneal area

研究概览

简要总结

The study objective is to assess safety and efficacy of photo-activation of riboflavin for treatment of corneal neovascularization with or without concomitant inflammation and/or infection.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age or older
  • With active inflammation or infection causing vascularization and possibly melting of the cornea, or vessels extending into the cornea causing lipid deposition, or vascularization that could significantly increase the risk of rejection of a current or planned corneal transplant, or vessels that continue to extend into the cornea despite topical treatment with corticosteroids.
  • Signed written informed consent.

排除标准

  • Known sensitivity to treatment medications
  • Current condition that in the investigator's opinion could compromise safety or data integrity.
  • Pregnancy (including plan to become pregnant) or lactation during the course of the study

结局指标

主要结局

corneal neovascularization as a proportion of the total corneal area

时间窗: 6 months

the cornea will be photographed and morphometric image analysis software will be used to measure corneal neovascularization as a proportion of the total corneal area. The proportion measured at baseline will be compared with the proportion measured at 6 months after treatment.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验